Cargando…

Review of mathematical models of HSV-2 vaccination: Implications for vaccine development

Development of a vaccine against herpes simplex virus type 2 (HSV-2), a life-long sexually-transmitted infection (STI), would be a major step forward in improving global sexual and reproductive health. In this review, we identified published literature of dynamic mathematical models assessing the im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spicknall, Ian H., Looker, Katharine J., Gottlieb, Sami L., Chesson, Harrell W., Schiffer, Joshua T., Elmes, Jocelyn, Boily, Marie-Claude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892260/ https://www.ncbi.nlm.nih.gov/pubmed/29625767 http://dx.doi.org/10.1016/j.vaccine.2018.02.067

Ejemplares similares

Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis
por: Looker, Katharine J, et al.
Publicado: (2017)

The population impact of herpes simplex virus type 2 (HSV-2) vaccination on the incidence of HSV-2, HIV and genital ulcer disease in South Africa: a mathematical modelling study
por: Stone, Jack, et al.
Publicado: (2023)

The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study
por: Looker, Katharine Jane, et al.
Publicado: (2020)

Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data
por: Looker, Katharine J, et al.
Publicado: (2020)

HSV-2 Vaccine: Current Status and Insight into Factors for Developing an Efficient Vaccine
por: Zhu, Xiao-Peng, et al.
Publicado: (2014)

Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses
por: Ayoub, Houssein H., et al.
Publicado: (2020)

Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa
por: Schiffer, Joshua T., et al.
Publicado: (2016)

Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis — United States, May 2022–April 2023
por: Kota, Krishna Kiran, et al.
Publicado: (2023)

Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs
por: Bernard, Marie-Clotilde, et al.
Publicado: (2015)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women
por: Gilbert, Peter B., et al.
Publicado: (2017)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status
por: Looker, Katharine J, et al.
Publicado: (2018)

Utility of a Recombinant HSV-1 Vaccine Vector for Personalized Cancer Vaccines
por: Uche, Ifeanyi Kingsley, et al.
Publicado: (2022)

Dynamics of HSV-2 infection with a therapeutic vaccine
por: Venturino, Ezio, et al.
Publicado: (2020)

In Situ Cancer Vaccination and Immunovirotherapy Using Oncolytic HSV
por: Jahan, Nusrat, et al.
Publicado: (2021)

Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?
por: Drolet, Mélanie, et al.
Publicado: (2013)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States
por: Chesson, Harrell W., et al.
Publicado: (2008)

Herpes Simplex Virus 2 (HSV-2) Infected Cell Proteins Are among the Most Dominant Antigens of a Live-Attenuated HSV-2 Vaccine
por: Geltz, Joshua J., et al.
Publicado: (2015)

A Replication-Defective Herpes Simplex Virus (HSV)-2 Vaccine, HSV529, is Safe and Well-Tolerated in Adults with or without HSV Infection and Induces Significant HSV-2-Specific Antibody Responses in HSV Seronegative Individuals
por: Dropulic, Lesia, et al.
Publicado: (2017)

Mucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future Protection
por: Schiffer, Joshua T.
Publicado: (2013)

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022)

Racial and Ethnic Disparities in Mpox Cases and Vaccination Among Adult Males — United States, May–December 2022
por: Kota, Krishna Kiran, et al.
Publicado: (2023)

Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study
por: Looker, Katharine J, et al.
Publicado: (2015)

Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development
por: Galli, Jennifer D., et al.
Publicado: (2022)

Cost-effectiveness of Chlamydia Vaccination Programs for Young Women
por: Owusu-Edusei, Kwame, et al.
Publicado: (2015)

Successful application of prime and pull strategy for a therapeutic HSV vaccine
por: Bernstein, David I., et al.
Publicado: (2019)

How common and frequent is heterosexual anal intercourse among South Africans? A systematic review and meta-analysis
por: Owen, Branwen N., et al.
Publicado: (2017)

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission
por: Swan, David A., et al.
Publicado: (2021)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Neurotrophic Factors NGF, GDNF and NTN Selectively Modulate HSV1 and HSV2 Lytic Infection and Reactivation in Primary Adult Sensory and Autonomic Neurons
por: Yanez, Andy A., et al.
Publicado: (2017)

Increases in HIV Incidence Following Receptive Anal Intercourse Among Women: A Systematic Review and Meta-analysis
por: Stannah, James, et al.
Publicado: (2019)

Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity
por: Burn Aschner, Clare, et al.
Publicado: (2020)

A Herpes Simplex Virus 2 (HSV-2) Glycoprotein D-expressing Nonreplicating Dominant-Negative HSV-2 Virus Vaccine Is Superior to a gD2 Subunit Vaccine against HSV-2 Genital Infection in Guinea Pigs
por: Zhang, Pengwei, et al.
Publicado: (2014)

Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis
por: Naidu, Shan K., et al.
Publicado: (2020)

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
por: Petrosky, Emiko, et al.
Publicado: (2015)

The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model
por: Bernstein, David I., et al.
Publicado: (2020)

Correction: Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
por: Looker, Katharine J., et al.
Publicado: (2015)

Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
por: Looker, Katharine J., et al.
Publicado: (2015)

Optimizing vaccine allocation for COVID-19 vaccines: potential role of single-dose vaccination.
por: Matrajt, Laura, et al.
Publicado: (2021)

Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening
por: Boily, Marie-Claude, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_makf8diu65s4b3tnmh2vp2q847